Prudential plc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,480	Closed	-$1.65M	–	695
2025 Q3	$1.65M	Hold	30,480	–	–	0.01%	411
2025 Q2	$1.68M	Buy	30,480 +24,114	+379%	+$1.42M	0.01%	431
2025 Q1	$450K	Buy	+6,366	New	+$428K	﹤0.01%	611
2024 Q1	–	Sell	-7,053	Closed	-$680K	–	761
2023 Q4	$680K	Sell	7,053 -19	-0.3%	-$1.68K	0.01%	691
2023 Q3	$626K	Sell	7,072 -1,658	-19%	-$148K	0.01%	679
2023 Q2	$757K	Sell	8,730 -94	-1%	-$8.85K	0.01%	671
2023 Q1	$858K	Buy	8,824 +1,395	+19%	+$145K	0.01%	607
2022 Q4	$769K	Buy	7,429 +3,599	+94%	+$338K	0.01%	642
2022 Q3	$325K	Sell	3,830 -12,293	-76%	-$1.09M	0.01%	687
2022 Q2	$1.34M	Sell	16,123 -6,708	-29%	-$534K	0.02%	356
2022 Q1	$1.76M	Buy	22,831 +2,952	+15%	+$247K	0.03%	329
2021 Q4	$1.76M	Sell	19,879 -691	-3%	-$57K	0.02%	290
2021 Q3	$1.59M	Buy	+20,570	New	+$1.62M	0.02%	263